| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.09 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.77 | 0.003 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.004 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.3 | 0.004 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.006 |